Cargando…

Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation

BACKGROUND: Malignant pleural mesothelioma (MPM) is a devastating disease with an overall poor prognosis. Despite the recent advances in targeted molecular therapies, there is a clear and urgent need for the identification of novel mesothelioma targets for the development of highly efficacious thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalari, Satish, Moolky, Nagabhushan, Pendyala, Srikanth, Berdyshev, Evgeny V., Rolle, Cleo, Kanteti, Rajani, Kanteti, Archana, Ma, Wenli, He, Donghong, Husain, Aliya N., Kindler, Hedy L., Kanteti, Prasad, Salgia, Ravi, Natarajan, Viswanathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444486/ https://www.ncbi.nlm.nih.gov/pubmed/23028939 http://dx.doi.org/10.1371/journal.pone.0045330

Ejemplares similares

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism
por: Loganathan, Sivakumar, et al.
Publicado: (2011)

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2016)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma
por: Lennon, Frances E., et al.
Publicado: (2016)

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma
por: Carey, George B, et al.
Publicado: (2012)

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
por: Tan, Yi-Hung Carol, et al.
Publicado: (2019)

Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2018)

FAK and paxillin, two potential targets in pancreatic cancer
por: Kanteti, Rajani, et al.
Publicado: (2016)

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
por: Kanteti, Rajani, et al.
Publicado: (2014)

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
por: Hasina, Rifat, et al.
Publicado: (2013)

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
por: Surati, Mosmi, et al.
Publicado: (2011)

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma
por: Rolle, Cleo E., et al.
Publicado: (2016)

Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia
por: Natarajan, Viswanathan, et al.
Publicado: (2017)

The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target
por: Ferguson, Benjamin D., et al.
Publicado: (2013)

Role of lysophosphatidic acid receptor LPA(2 )in the development of allergic airway inflammation in a murine model of asthma
por: Zhao, Yutong, et al.
Publicado: (2009)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Studies on the Effect of Oil and Surfactant on the Formation of Alginate-Based O/W Lidocaine Nanocarriers Using Nanoemulsion Template
por: Sarheed, Omar, et al.
Publicado: (2020)

A Rare Case of Plasma Cell Granuloma
por: Kanteti, Archana P., et al.
Publicado: (2020)

Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase
por: Berdyshev, Evgeny V., et al.
Publicado: (2011)

Systemic Treatments for Mesothelioma: Standard and Novel
por: Kindler, Hedy Lee
Publicado: (2008)

Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant
por: Sarheed, Omar, et al.
Publicado: (2021)

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer
por: Ferguson, Benjamin D., et al.
Publicado: (2015)

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database
por: Surati, Mosmi, et al.
Publicado: (2011)

Medullary Thyroid Carcinoma Presenting as Metastatic Disease to the Breast
por: Kanteti, Archana P., et al.
Publicado: (2020)

Sphingolipids in Ventilator Induced Lung Injury: Role of Sphingosine-1-Phosphate Lyase
por: Suryadevara, Vidyani, et al.
Publicado: (2018)

C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype
por: Kanteti, Rajani, et al.
Publicado: (2015)

The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis
por: Barkinge, John L., et al.
Publicado: (2009)

Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
por: White, Michael G., et al.
Publicado: (2020)

The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization
por: Lo, Fang-Yi, et al.
Publicado: (2012)

The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells
por: Tonelli, Francesca, et al.
Publicado: (2013)

Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta
por: Xie, Lishi, et al.
Publicado: (2016)

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
por: Tan, Yi-Hung Carol, et al.
Publicado: (2010)

Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020)

Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
por: Tan, Yi-Hung Carol, et al.
Publicado: (2011)

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
por: Chapel, David B., et al.
Publicado: (2020)

Albumin Nanoparticle Endocytosing Subset of Neutrophils for Precision Therapeutic Targeting of Inflammatory Tissue Injury
por: Bachmaier, Kurt, et al.
Publicado: (2022)

MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells
por: Turner, Andrea, et al.
Publicado: (2013)

Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
por: Mitchell, Owen D., et al.
Publicado: (2023)

A phase 2 randomized, double-blind, placebo-controlled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma
por: Krug, Lee, et al.
Publicado: (2013)

Coronin 1B Regulates S1P-Induced Human Lung Endothelial Cell Chemotaxis: Role of PLD2, Protein Kinase C and Rac1 Signal Transduction
por: Usatyuk, Peter V., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v2c6l9l0uvj4f74n2eol49a0un